Seer (NASDAQ:SEER) Shares Down 2.8% – Here’s What Happened

Seer, Inc. (NASDAQ:SEER) fell 2.8% during mid-day trading on Friday . The stock traded as low as $1.76 and last traded at $1.76. 295,349 shares were traded during mid-day trading, an increase of 78% from the average session volume of 165,752 shares. The stock had previously closed at $1.81.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on SEER. Weiss Ratings restated a “sell (d-)” rating on shares of Seer in a report on Wednesday, October 8th. Wall Street Zen raised Seer to a “hold” rating in a research report on Saturday. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Seer Trading Down 2.8%

The stock has a market cap of $98.19 million, a P/E ratio of -1.29 and a beta of 1.60. The company’s fifty day simple moving average is $2.08 and its 200-day simple moving average is $2.10.

Seer (NASDAQ:SEER) last released its quarterly earnings data on Thursday, November 6th. The company reported ($0.32) EPS for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.01. Seer had a negative net margin of 484.51% and a negative return on equity of 25.88%. The company had revenue of $4.12 million during the quarter, compared to the consensus estimate of $4.00 million. As a group, analysts expect that Seer, Inc. will post -1.42 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Omid Farokhzad sold 33,838 shares of the company’s stock in a transaction that occurred on Wednesday, November 19th. The stock was sold at an average price of $1.97, for a total value of $66,660.86. Following the sale, the chief executive officer directly owned 1,238,230 shares in the company, valued at approximately $2,439,313.10. This represents a 2.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 11.28% of the company’s stock.

Hedge Funds Weigh In On Seer

Hedge funds and other institutional investors have recently modified their holdings of the stock. Occudo Quantitative Strategies LP bought a new stake in Seer in the second quarter valued at $25,000. Quadrature Capital Ltd bought a new position in shares of Seer during the second quarter valued at $47,000. OMERS ADMINISTRATION Corp boosted its stake in shares of Seer by 54.3% in the 1st quarter. OMERS ADMINISTRATION Corp now owns 76,200 shares of the company’s stock valued at $129,000 after purchasing an additional 26,819 shares in the last quarter. Corient Private Wealth LLC grew its holdings in shares of Seer by 46.3% in the 2nd quarter. Corient Private Wealth LLC now owns 63,200 shares of the company’s stock worth $135,000 after purchasing an additional 20,000 shares during the last quarter. Finally, Shay Capital LLC grew its holdings in shares of Seer by 17.7% in the 3rd quarter. Shay Capital LLC now owns 73,571 shares of the company’s stock worth $160,000 after purchasing an additional 11,073 shares during the last quarter. Institutional investors own 75.20% of the company’s stock.

Seer Company Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.